FDA Approves Bimzelx for Inflammatory Skin Disease
hidradenitis suppurativa © Lea - stock.adobe.comUCB announced today that the FDA has approved Bimzelx (bimekizumab-bkzx) for the treatment of moderate-to-severe...
inflammatory
FDA Sets Date For Resubmitted Dupixent in Inflammatory Skin Disease
The FDA has accepted the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric...
Patient-reported assessment of medical care for chronic inflammatory skin diseases: an enterprise-based survey
1 Introduction Chronic inflammatory skin diseases (CISDs) are among the most common diseases in the Western world. A recent survey...
